Learn More
Learn More
Learn More
Learn More
Learn More
Development of therapeutic antibodies against immune checkpoints for the treatment of melanoma and other cancers is gaining momentum among academia and the pharmaceutical industry.
08-15-2017 XinPo Jiang, Ph.D. and Amy Mendenhall, Ph.D.
Wouldn't it be great if all the supplies you needed to obtain preliminary data for your next grant were available from the same vendor? This webinar will show you how to incorporate
06-28-2017 Amy Mendenhall, Ph.D.
Long-term delivery of neutralizing antibodies by means of recombinant adeno-associated virus (rAAV) is a novel and promising approach for the prevention
06-26-2017 Keshav
Are you currently working on a Therapeutic Antibody project and looking for ways to accelerate your program? If yes, this webinar may be for you.
05-05-2017 Keshav Vasanthavada
While CRISPR/Cas9 editing is utilized in a wide variety of cell types, editing efficiency continues to pose a challenge to researchers.
04-18-2017 Dr. Allison Mayle
Therapeutic antibody drugs show significant growth rate. Within oncology research alone, more than 20 therapeutic antibody drugs received FDA approval for new treatments or indications during 2015 and 2016. In addition, more than 300 therapeutic antibody
04-12-2017 Liusong Yin, Ph.D.